REG - Fadel Partners Inc. - Grant of Options

Fadel PartnersAnnouncement

22/10/2025 15:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251022:nRSV4426Ea&default-theme=true

RNS Number : 4426E  Fadel Partners Inc.  22 October 2025

 

Fadel Partners, Inc.

('FADEL', the 'Company' or, together with its subsidiaries, the 'Group')

Grant of Options

 

On 22 October 2025 Mark Plotkin, Chief Financial Officer, was awarded the
following options over the Company's common shares of US $0.001 par value
each ("Common Shares") under the FADEL 2023 Equity Incentive Plan ("Plan"):

 

 Name of PDMR   Number of share options granted  Exercise price  Total number of share options held following this notification  Total number of share options as % of current issued share capital

 Mark Plotkin   202,312                          GBP£0.65        202,312                                                         1.00%

 

 

The market priced share options granted to Mark Plotkin on 22 October 2025
shall become 25% vested and exercisable on the twelve-month anniversary of the
date of grant, 22 October 2026, with the remaining balance of option shares
becoming vested and exercisable in 36 equal monthly installments commencing
with the month following the twelve-month anniversary of the grant date.

 

Including the above grant, the number of options over Common Shares granted
under the Plan now represents 7.92% of the Company's current issued share
capital.

 

This announcement contains inside information for the purposes of the
retained UK version of the EU Market Abuse Regulation (EU) 596/2014
("UK MAR").

 

For further information please contact:

 Tarek Fadel, Chief Executive Officer

 Mark Plotkin, Chief Financial Officer

 Cavendish Capital Markets Limited (Nomad & Broker)        Tel: +44(0)20 7220 0500
 Jonny-Franklin Adams, Isaac Hooper (Corporate Finance)
 Tim Redfern, Sunila De Silva (ECM)

 FADEL Strategic Communications                            Tel: +44(0)20 3405 0205
 Devi Gupta - press@fadel.com

 

 

Details of the transaction are reported in the PDMR notification below:

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated

 a)  Name                                                         Mark Plotkin
 2   Reason for the notification

 a)  Position/status                                              Chief Financial Officer

 b)  Initial notification/Amendment                               Initial Notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Fadel Partners, Inc.
 b)  LEI                                                          2138006CF39FSLKDRZ65
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted

 a)  Description of the financial instrument, type of instrument  Grant of options for 202,312 common shares of US $0.001 par value each.

                                                                  ISIN: USU3033R1024

 c)  Currency                                                     GBP£
 d)  Price(s) and volumes(s)                                      Price(s)                                Volume(s)
                                                                  GBP£0.65                                202,312
 e)  Aggregated information                                       As above

     -      Aggregated volume

     -      Price

 f)  Date of the transaction                                      22 October 2025
 g)  Place of the transaction                                     NA (grant of options)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHZLLFLEBLXFBX



            Copyright 2019 Regulatory News Service, all rights reserved